Independent and joint contributions of physical disability and chronic pain to incident opioid use disorder and opioid overdose among Medicaid patients.
Psychol Med.
2024 May;54(7):1419-1430. doi: 10.1017/S003329172300332X. Epub 2023 Nov 17. PubMed PMID:
37974483; PubMed Central PMCID:
PMC10994776.
Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States, 2004-2019.
Drug Alcohol Depend.
2024 Apr 1;257:111113. doi: 10.1016/j.drugalcdep.2024.111113. Epub 2024 Feb 2. PubMed PMID:
38382162.
Association of medications for opioid use disorder with reduced risk of repeat opioid overdose in Medicaid: A cohort study.
J Subst Use Addict Treat.
2024 Feb;157:209218. doi: 10.1016/j.josat.2023.209218. Epub 2023 Nov 19. PubMed PMID:
37984564; PubMed Central PMCID:
PMC10922317.
Suicide within 1 year of non-fatal overdose: Risk factors and risk reduction with medications for opioid use disorder.
Gen Hosp Psychiatry.
2024 Jan-Feb;86:24-32. doi: 10.1016/j.genhosppsych.2023.11.003. Epub 2023 Nov 4. PubMed PMID:
38061284; PubMed Central PMCID:
PMC10880030.
Racial/ethnic disparities in timely receipt of buprenorphine among Medicare disability beneficiaries.
Drug Alcohol Depend.
2023 Nov 1;252:110963. doi: 10.1016/j.drugalcdep.2023.110963. Epub 2023 Sep 14. PubMed PMID:
37748421; PubMed Central PMCID:
PMC10615876.
Association Between Legal Access to Medical Cannabis and Frequency of Non-Medical Prescription Opioid Use among US Adults.
International Journal of Mental Health and Addiction. 2023 October. NIHMSID: NIHMS1967300.
Racial And Ethnic Disparities In Buprenorphine Receipt Among Medicare Beneficiaries, 2015-19.
Health Aff (Millwood).
2023 Oct;42(10):1431-1438. doi: 10.1377/hlthaff.2023.00205. PubMed PMID:
37782874; PubMed Central PMCID:
PMC10910625.
Buprenorphine After Nonfatal Opioid Overdose: Reduced Mortality Risk in Medicare Disability Beneficiaries.
Am J Prev Med.
2023 Jul;65(1):19-29. doi: 10.1016/j.amepre.2023.01.037. Epub 2023 Mar 10. PubMed PMID:
36906496; PubMed Central PMCID:
PMC10293066.
Performance Measurement for Opioid Use Disorder Medication Treatment and Care Retention.
Am J Psychiatry.
2023 Jun 1;180(6):454-457. doi: 10.1176/appi.ajp.20220456. Epub 2022 Oct 26. PubMed PMID:
36285405; PubMed Central PMCID:
PMC10130230.
Association of a State Prescribing Limits Policy with Opioid Prescribing and Long-term Use: an Interrupted Time Series Analysis.
J Gen Intern Med.
2023 Jun;38(8):1862-1870. doi: 10.1007/s11606-022-07991-7. Epub 2023 Jan 6. PubMed PMID:
36609812; PubMed Central PMCID:
PMC10271990.
Buprenorphine Utilization and Prescribing Among New Jersey Medicaid Beneficiaries After Adoption of Initiatives Designed to Improve Treatment Access.
JAMA Netw Open.
2023 May 1;6(5):e2312030. doi: 10.1001/jamanetworkopen.2023.12030. PubMed PMID:
37145594; PubMed Central PMCID:
PMC10163388.
Naloxone expansion is not associated with increases in adolescent heroin use and injection drug use: Evidence from 44 US states.
Int J Drug Policy.
2023 Apr;114:103980. doi: 10.1016/j.drugpo.2023.103980. Epub 2023 Feb 28. PubMed PMID:
36863285.
A modified Delphi process to identify experts' perceptions of the most beneficial and harmful laws to reduce opioid-related harm.
Int J Drug Policy.
2022 Oct;108:103809. doi: 10.1016/j.drugpo.2022.103809. Epub 2022 Jul 28. PubMed PMID:
35908313; NIHMSID:NIHMS1840454.
Psychosocial and behavioral therapy in conjunction with medication for opioid use disorder: Patterns, predictors, and association with buprenorphine treatment outcomes.
J Subst Abuse Treat.
2022 Aug;139:108774. doi: 10.1016/j.jsat.2022.108774. Epub 2022 Mar 18. PubMed PMID:
35337716; PubMed Central PMCID:
PMC9187597.
Non-prescribed buprenorphine preceding treatment intake and clinical outcomes for opioid use disorder.
J Subst Abuse Treat.
2022 Aug;139:108770. doi: 10.1016/j.jsat.2022.108770. Epub 2022 Mar 21. PubMed PMID:
35337715; PubMed Central PMCID:
PMC9187606.
Commentary on Lo-Ciganic et al.: The importance of evidence-based clinical and policy approaches to reduce opioid harms.
Addiction.
2022 Jul;117(7):1998-1999. doi: 10.1111/add.15915. Epub 2022 May 11. PubMed PMID:
35543359; PubMed Central PMCID:
PMC9203928.
Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic.
JAMA Netw Open.
2022 Jun 1;5(6):e2214765. doi: 10.1001/jamanetworkopen.2022.14765. PubMed PMID:
35648400; PubMed Central PMCID:
PMC9161014.
Benzodiazepine and Stimulant Prescriptions Before Overdose in Youth.
Pediatrics.
2022 Apr 1;149(4). doi: 10.1542/peds.2021-055226. PubMed PMID:
35233611; PubMed Central PMCID:
PMC9097826.
Opioid overdose survivors: Medications for opioid use disorder and risk of repeat overdose in Medicaid patients.
Drug Alcohol Depend.
2022 Mar 1;232:109269. doi: 10.1016/j.drugalcdep.2022.109269. Epub 2022 Jan 10. PubMed PMID:
35038609; PubMed Central PMCID:
PMC8943804.
Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.
JAMA Netw Open.
2022 Mar 1;5(3):e223821. doi: 10.1001/jamanetworkopen.2022.3821. PubMed PMID:
35319762; PubMed Central PMCID:
PMC8943638.
Medically treated opioid overdoses among New Jersey Medicaid beneficiaries: Rapid growth and complex comorbidity amid growing fentanyl penetration.
J Subst Abuse Treat.
2021 Dec;131:108546. doi: 10.1016/j.jsat.2021.108546. Epub 2021 Jun 24. PubMed PMID:
34391586; PubMed Central PMCID:
PMC8664984.
Prescription Opioid Laws and Opioid Dispensing in US Counties: Identifying Salient Law Provisions With Machine Learning.
Epidemiology.
2021 Nov 1;32(6):868-876. doi: 10.1097/EDE.0000000000001404. PubMed PMID:
34310445; PubMed Central PMCID:
PMC8556655.
Proceedings of the Addiction Health Services Research (AHSR) 2020: Virtual Conference: Part 2.
Addict Sci Clin Pract.
2020 Dec 30;15(Suppl 2):35. doi: 10.1186/s13722-020-00208-4. PubMed PMID:
33375945; PubMed Central PMCID:
PMC7772004.
Discussing Drug Use With Health Care Providers Is Associated With Perceived Need and Receipt of Drug Treatment Among Adults in the United States: We Need to Talk.
Med Care.
2020 Jul;58(7):617-624. doi: 10.1097/MLR.0000000000001340. PubMed PMID:
32520836; PubMed Central PMCID:
PMC8112806.
Impact Of Long-Term Buprenorphine Treatment On Adverse Health Care Outcomes In Medicaid.
Health Aff (Millwood).
2020 May;39(5):747-755. doi: 10.1377/hlthaff.2019.01085. PubMed PMID:
32364847; PubMed Central PMCID:
PMC7531057.
Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder.
Am J Psychiatry.
2020 Feb 1;177(2):117-124. doi: 10.1176/appi.ajp.2019.19060612. Epub 2019 Dec 2. PubMed PMID:
31786933; PubMed Central PMCID:
PMC7002204.
The Role of Screening in Depression Diagnosis and Treatment in a Representative Sample of US Primary Care Visits.
J Gen Intern Med.
2020 Jan;35(1):12-20. doi: 10.1007/s11606-019-05192-3. Epub 2019 Aug 6. PubMed PMID:
31388917; PubMed Central PMCID:
PMC6957618.
Opioid Use and Misuse and Suicidal Behaviors in a Nationally Representative Sample of US Adults.
Am J Epidemiol.
2019 Jul 1;188(7):1245-1253. doi: 10.1093/aje/kwz061. PubMed PMID:
30834448; PubMed Central PMCID:
PMC6601526.
Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees.
J Subst Abuse Treat.
2018 Dec;95:9-17. doi: 10.1016/j.jsat.2018.09.001. Epub 2018 Sep 7. PubMed PMID:
30352671; PubMed Central PMCID:
PMC6354252.
Tobacco Screening and Counseling in the U.S.: Smokers With Mental Health and Substance Use Problems.
Am J Prev Med.
2018 Oct;55(4):524-532. doi: 10.1016/j.amepre.2018.05.024. Epub 2018 Aug 19. PubMed PMID:
30135038; PubMed Central PMCID:
PMC6363105.
Is screening and intervention associated with treatment receipt among individuals with alcohol use disorder? Evidence from a national survey.
J Subst Abuse Treat.
2018 Sep;92:85-90. doi: 10.1016/j.jsat.2018.06.009. Epub 2018 Jun 22. PubMed PMID:
30032949; PubMed Central PMCID:
PMC6423981.
Mental Health Spending and Intensity of Service Use Among Individuals With Diagnoses of Eating Disorders Following Federal Parity.
Psychiatr Serv.
2018 Feb 1;69(2):217-223. doi: 10.1176/appi.ps.201600516. Epub 2017 Nov 15. PubMed PMID:
29137561; PubMed Central PMCID:
PMC5794569.
The emerging public discourse on state legalization of marijuana for recreational use in the US: Analysis of news media coverage, 2010-2014.
Prev Med.
2016 Sep;90:114-20. doi: 10.1016/j.ypmed.2016.06.040. Epub 2016 Jun 30. PubMed PMID:
27373208; PubMed Central PMCID:
PMC6983281.
Antidepressant self-discontinuation: results from the collaborative psychiatric epidemiology surveys.
Psychiatr Serv.
2015 May 1;66(5):455-62. doi: 10.1176/appi.ps.201400021. Epub 2014 Dec 15. PubMed PMID:
25930223.
Current practices of the child neurologist in managing sports concussion.
J Child Neurol.
2014 Jan;29(1):17-22. doi: 10.1177/0883073812464525. Epub 2012 Nov 8. PubMed PMID:
23143716.
Antidepressant use in the European union: perceived indications and patterns.
Psychiatr Serv.
2013 Mar 1;64(3):208. doi: 10.1176/appi.ps.005622012. PubMed PMID:
23450382.
The relationship between psychological distress and baseline sports-related concussion testing.
Clin J Sport Med.
2010 Jul;20(4):272-7. doi: 10.1097/JSM.0b013e3181e8f8d8. PubMed PMID:
20606512.
What would you like to do?